Te-Wei Wang il 22/01/2026

Updates on hereditary transthyretin amyloidosis polyneuropathy

J Formos Med Assoc. 2026 Jan 21:S0929-6646(26)00041-0. doi: 10.1016/j.jfma.2026.01.023. Online ahead of print.ABSTRACTHereditary transthyretin amyloidosis (ATTRv) is a fatal autosomal dominant disorder caused by pathogenic variants in the TTR gene. Various variants cause destabilization of transthyr

Elisa Leggeri il 22/01/2026

No mistakes with Schnitzler syndrome

Praxis (Bern 1994). 2025 Dec;114(12):434-437. doi: 10.23785/PRAXIS.2025.12.007.ABSTRACTSchnitzler syndrome is a rare autoinflammatory disease that primarily manifests in adulthood. In cases presenting with chronic urticaria and paraproteinemia, Schnitzler syndrome should be considered in the differe

Veenu Singla il 21/01/2026

Beyond the breast: Mammographic manifestations of systemic disease

Curr Probl Diagn Radiol. 2026 Jan 13:S0363-0188(26)00003-4. doi: 10.1067/j.cpradiol.2026.01.003. Online ahead of print.ABSTRACTMammography is traditionally regarded as a domain confined to the detection of breast malignancies; however, it can also serve as a mirror for diverse systemic, haematologic

Kevin Zambrano Zambrano il 21/01/2026

AL Cardiac Amyloidosis Presenting as Grade 3 ATTR Mimicry on Scintigraphy

JACC Case Rep. 2025 Dec 30:106595. doi: 10.1016/j.jaccas.2025.106595. Online ahead of print.ABSTRACTBACKGROUND: Grade 2 or 3 uptake on 99mTc-pyrophosphate scintigraphy is a cornerstone for diagnosing transthyretin amyloidosis. However, light-chain amyloidosis can infrequently mimic this pattern, cau

Sophie Friedman il 20/01/2026

2025 New Drug Update (Part 2): Recent Approvals and Clinical Implications

Sr Care Pharm. 2026 Jan 1;41(1):3-12. doi: 10.4140/TCP.n.2026.3.ABSTRACTWith the increasing prevalence of polypharmacy, age-related physiological changes, and the need for individualized pharmacotherapy in older patients, understanding new drug approvals is crucial to optimizing medication managemen

Carolina Mercado il 19/01/2026

Ocular Surface Squamous Neoplasia Masqueraders

Semin Ophthalmol. 2026 Feb;41(2):331-341. doi: 10.1080/08820538.2025.2548021. Epub 2025 Aug 26.ABSTRACTPURPOSE: To describe common ocular surface lesions that clinically mimic ocular surface squamous neoplasia (OSSN) and provide practical guidance for their accurate identification using anterior seg